- Home
- AMLX vs ALM Comparison
AMLX vs ALM Comparison
Compare AMLX & ALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMLX | ALM |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | 136 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.8B |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | AMLX | ALM |
|---|---|---|
| Price | $27.68 | $8.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $42.64 | $23.69 |
| AVG Volume (30 Days) | 1.3M | ★ 6.8M |
| Earning Date | 11-05-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $380,786,000.00 | N/A |
| Revenue This Year | N/A | $833.88 |
| Revenue Next Year | N/A | $216.82 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $10.83 | $5.44 |
| 52 Week High | $41.14 | $24.41 |
Technical Indicators
Market Signals| Indicator | AMLX | ALM |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 32.15 |
| Support Level | $26.16 | $8.39 |
| Resistance Level | $34.35 | $9.78 |
| Average True Range (ATR) | 1.48 | 0.65 |
| MACD | 0.28 | 0.11 |
| Stochastic Oscillator | 70.80 | 19.63 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About ALM Almonty Industries Inc.
Almonty Industries Inc is engaged in the development of the Sangdong Mine in South Korea, and the Company is currently mining, processing, and shipping tungsten concentrate from the Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal (Panasqueira Mine). Additionally, the Company is evaluating its molybdenum project with inferred mineral resources on a separate property adjacent to the tungsten orebody at the Sangdong Mine, its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora (Valtreixal Mine), and the newly-acquired Gentung Browns Lake tungsten project located in Montana, USA (Gentung-Browns Lake Project). The company has two geographical locations: the Iberian Peninsula (Spain and Portugal) and the Republic of Korea.